OS
Operating Division	OPDIV Contact	OPDIV Phone	Sequence Num	Solicitation Release Qtr	Procurement Method	Procurement Category	NAICS	Estimated Cost Range	Description	Incumbant (If any):
OS	Paquetta Myrick-Hancock	(202)-260-0534	0001	4th Qtr FY2008	Full & Open	Construction	236210	5) $10,000,001 and above	Building Domestic Cell-based Influenza Vaccine Manufacturing Facilities - The purpose of this project is to expand the domestic manufacturing surge capacity influenza vaccine; this project includes developing the manufacturing infrastructure building to achieve a national pandemic prepardedness goal. Each contractor will have the capacity to provide 150 million initial doses of pandemic influenza vaccine within six months of pandemic onset.
OS	Kim Hall	(202)-205-1587	0003	4th Qtr FY2008	Full & Open	Research & Development	339112	4) $5,000,001 to $10,000,000	Advanced Development of Next Generation Portable Ventilators- Development of domestically manufactured next generation portable ventilators to provide respiratory support for large numbers of severely ill patients during a pandemic influenza outbreak.
OS	Vijaya Murthy	(202)-205-1855	0004	4th Qtr FY2008	To be determined	Research & Development	325414	5) $10,000,001 and above	Advanced Development of New Antiviral Agents Against Influenza Virus- Development of antiviral drugs and biologicals against the influenza virus. Efforts funded shall lead to U.S. licensure of an influenza antiviral drug or therapeutic that can be used to protect the U.S. population in the event of an influenza pandemic.